Eagle Asset Management Inc. Has $2.79 Million Stock Position in IQVIA Holdings Inc. (NYSE:IQV)

Eagle Asset Management Inc. boosted its stake in shares of IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 38.7% during the third quarter, according to its most recent disclosure with the SEC. The institutional investor owned 12,733 shares of the medical research company's stock after purchasing an additional 3,553 shares during the period. Eagle Asset Management Inc.'s holdings in IQVIA were worth $2,791,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in IQV. Advisors Asset Management Inc. lifted its holdings in shares of IQVIA by 106.4% during the 1st quarter. Advisors Asset Management Inc. now owns 1,298 shares of the medical research company's stock valued at $328,000 after buying an additional 669 shares during the last quarter. Caxton Associates LP bought a new stake in IQVIA in the first quarter worth approximately $842,000. B. Riley Wealth Advisors Inc. increased its stake in shares of IQVIA by 13.9% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 3,568 shares of the medical research company's stock worth $902,000 after purchasing an additional 436 shares during the last quarter. Meiji Yasuda Life Insurance Co raised its holdings in shares of IQVIA by 24.0% during the 1st quarter. Meiji Yasuda Life Insurance Co now owns 1,810 shares of the medical research company's stock valued at $458,000 after purchasing an additional 350 shares in the last quarter. Finally, California State Teachers Retirement System lifted its stake in shares of IQVIA by 1.2% in the 1st quarter. California State Teachers Retirement System now owns 300,804 shares of the medical research company's stock valued at $76,070,000 after purchasing an additional 3,663 shares during the last quarter. Institutional investors and hedge funds own 89.62% of the company's stock.

IQVIA Price Performance

NYSE IQV traded down $2.78 on Tuesday, hitting $201.24. 1,370,041 shares of the company were exchanged, compared to its average volume of 1,178,988. IQVIA Holdings Inc. has a 1-year low of $187.62 and a 1-year high of $261.73. The firm has a 50 day moving average of $221.18 and a two-hundred day moving average of $226.75. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 1.76. The company has a market cap of $36.53 billion, a P/E ratio of 26.41, a P/E/G ratio of 2.08 and a beta of 1.51.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on IQV. Royal Bank of Canada restated an "outperform" rating and set a $270.00 target price on shares of IQVIA in a report on Friday, November 1st. StockNews.com raised IQVIA from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. JPMorgan Chase & Co. cut their price objective on IQVIA from $279.00 to $240.00 and set an "overweight" rating for the company in a research report on Tuesday, November 5th. The Goldman Sachs Group lowered their target price on IQVIA from $280.00 to $250.00 and set a "buy" rating on the stock in a report on Friday, November 1st. Finally, TD Cowen reduced their price objective on IQVIA from $270.00 to $255.00 and set a "buy" rating for the company in a research report on Friday, November 1st. Four research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $256.50.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.